Align Technology, Inc. (ALGN) with a market cap of $11.2 billion, offers Invisalign clear aligners, Vivera retainers, and iTero intraoral scanners globally. Expected Q4 2025 results will be announced on Feb. 4, with analysts predicting a 26% profit increase. For fiscal 2025, a 16.7% EPS rise to $8.18 is forecasted.

ALGN stock has underperformed the S&P 500 and the State Street Health Care Select Sector SPDR ETF, dropping 22.5% over the past year. Following Q3 2025 results, shares surged 4.9% with adjusted EPS of $2.61 and revenue of $995.7 million, surpassing estimates. Analysts expect mid-single-digit growth in Clear Aligner volumes.

Analysts’ consensus rating on ALGN stock is cautiously optimistic, with a “Moderate Buy” rating and an average price target of $171.38, indicating a potential 2.2% upside. Out of 15 analysts, eight suggest “Strong Buys,” six “Holds,” and one a “Moderate Sell.”

Read more at Yahoo Finance: Here’s What to Expect From Align Technology’s Next Earnings Report